ABIONYX Pharma Reaches Another Key Milestone in the Industrialization of CER-001 by Entering into a Strategic Partnership with TEXCELL (ABL Diagnostics) for the Viral Safety and Clearance of Biologics
This press release is being prepared.
The market announcement is already indexed, but the document has not finished syncing to our storage yet.